Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

One of the challenges in treating patients with heart failure (HF) is achieving clinical stability and reducing the hospital readmission rate. A diuretic dose adjustment algorithm developed in the United States (Diuretic Treatment Algorithm, DTA) and later validated for use in Brazil (as the Algoritmo de Ajuste de Diurético, AAD) has proved feasible and readily applicable, but its effect on clinical outcomes has yet to be assessed. This report aims to describe a randomized clinical trial protocol designed to assess the effectiveness of the AAD and of nonpharmacologic management in improving clinical stability and reducing the readmission rate at 90 days in patients with HF.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Diuretics; Furosemide

Criteria

Inclusion Criteria:

• Patients of both genders

• Age ≥ 18 years

• Diagnosed with systolic HF

• Able to monitor body weight at home

• Using furosemide

Exclusion Criteria:

• Those who are not able to make return visits or participate in telephone contact, and those on renal replacement therapy.